このエントリーをはてなブックマークに追加
ID 30379
JaLCDOI
FullText URL
Author
Hamazaki, Keisuke
Gochi, Akira
Matsubara, Nagahide
Mori, Mazanobu
Orita, Kunzo
Abstract

Fas antigen (ag) is a cell surface protein known to trigger apoptosis in a variety of cells upon specific antibody binding. On the other hand, Bcl-2 protein, an oncogene product located at the mitochondrial inner surface, prolongs cell survival by blocking apoptosis. In this study we examined the expression of Fas ag and bcl-2 protein in 17 cases of hepatocellular carcinoma (HCC) to determine their role on HCC. By flow cytometric analysis, mean (SD) value of the expression of Fas ag on hepatocytes derived from normal liver, diseased liver (chronic hepatitis or liver cirrhosis) and HCC was 5.8 (4.7)%, 10.3 (6.9)%, and 24.0 (18.2)%, respectively. Fas ag expression on hepatoma cells was significantly greater than normal and diseased liver cells. The expression of Bcl-2 protein in normal liver, diseased liver and HCC was 4.3 (8.5)%, 0.8 (2.5)% and 2.1 (3.4)%, respectively, and the difference was not significant. These results suggest that induction of apoptosis may be a possible therapy against HCC.

Keywords
apoptosis
Fas antigen
Bcl-2
hepatocellular carcinoma
Amo Type
Article
Published Date
1995-08
Publication Title
Acta Medica Okayama
Volume
volume49
Issue
issue4
Publisher
Okayama University Medical School
Start Page
227
End Page
230
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
英語
File Version
publisher
Refereed
True
PubMed ID
Web of Sience KeyUT